Tag: #Global Trends

The United States is experiencing a significant increase in reported cyclosporiasis cases, a foodborne parasitic infection caused by Cyclospora cayetanensis.... Read more

The U.S. Food and Drug Administration (FDA) has approved an at home starting dose option for Leqembi (lecanemab), allowing eligible... Read more

Novo Nordisk has announced positive results from the Phase III FRONTIER4 extension study, reinforcing the long term safety and efficacy... Read more

AstraZeneca has expanded its oncology pipeline through a new licensing agreement with Dizal Pharmaceutical, securing global rights outside mainland China... Read more

India's healthcare investment landscape is entering a new phase as Maxivision Super Specialty Eye Hospitals, backed by private equity firm... Read more

GSK has reported encouraging Phase II clinical results for Jemperli (dostarlimab) in patients with locally advanced mismatch repair deficient (dMMR)... Read more

The understanding of obesity continues to evolve as medical experts increasingly recognize it as a chronic, relapsing disease rather than... Read more

The U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) reported that its oversight activities generated an... Read more

China Medical System (CMS) has entered into a research collaboration and licensing agreement with Insilico Medicine to develop innovative therapies... Read more